We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2024), originally scheduled for March 18-20 in Singapore, has been rescheduled to take place from September 19-21, 2024, in Rome, Italy.
If you have already confirmed your participation at the event, please note that your registration and accommodation (if previously booked with us) will automatically be transferred to the new dates.
For any further information or inquiries, please do not hesitate to contact us at pharmadds@magnusconference.com or call us at +1 (702) 988 2320.
A biologic is produced inside living system, like a microorganism, plant or animal cell, or both. The majority of biologics are huge, complex compounds or molecule mixtures. Recombinant DNA technology is used to make several biologics. Biologics are made from living systems that can be sensitive to even modest modifications in the manufacturing process. Small variations in the manufacturing process can have a big impact on the final biologic's composition and, more crucially, how it works in the body.
Any molecule created by living beings is referred to as a biomolecule. As a result, the vast majority of them are organic molecules. Polysaccharides, amino acids and proteins, nucleic acids (DNA and RNA), and lipids are the four major types of macromolecules found in and produced by living organisms. Over the last two decades, there has been a clear shift away from traditional chemically synthesized small molecule medications and toward large molecule biological drugs or biopharmaceuticals. Despite the fact that many analysts agree on this trend, it is unknown which biomolecules the pharmaceutical industry is currently using for biopharmaceuticals and which biomolecules are in their drug development pipelines that may become the next generation of biopharmaceuticals.
“Antibody-drug cell therapy products when the active ingredient is taken or synthesised from a biological source” are biotherapeutics. Biotherapeutics has become an important aspect of modern medicine, and it is increasingly being utilized to treat and prevent major illnesses, infections, and diseases.
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, Institute for Biotechnology & Global Health of the RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Antimicrobial electrospun fiber-based structures and their possible use as systems for delivering drugs to the skin
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Understanding ABC transporters to navigate human diseases
Ruchika Bajaj, University of California, United States
Title : Antibodies (Abs) with functionality (Ab-Proteases) as a new generation of translational tools designed get healthcare model re-armed and drug design enriched
Sergey Suchkov, Institute for Biotechnology & Global Health of the RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Drug discoveries and challenges for polymeric medical packaging devices
Anupam Chanda, Bioxytran Inc, India